Charles Zaloudek, MD

---

Additional Websites

• Physician Referral Directory

---

Education

University of California, Berkeley, CA, A.B., 1967
Johns Hopkins School of Medicine, Baltimore, MD, M.D., 1971, Medicine
Stanford University, Stanford, CA, Resident, 1971-73, Pathology
Stanford University, Stanford, CA, Fellow, 1973-74, Surgical Pathology

---

Professional Experience

• 1974-75
  American Cancer Society Clinical Fellow in Anatomic Pathology, MD Anderson Hospital and Tumor Institute, Univ. Texas System Cancer Center, Houston, TX
• 1975-77
  Staff Pathologist, DD Eisenhower Army Medical Center, Fort Gordon, GA
• 1975-77
  Clinical Assistant Professor of Pathology, Medical College of Georgia, Augusta, GA
• 1977-80
  Staff Pathologist, Dept. Gynecologic and Breast Pathology, George Washington Univ. School of Medicine, Washington, DC
• 1980-83
  Assistant Professor of Pathology, George Washingon Univ. School of Medicine
• 1983-86
  Associate Professor of Pathology, George Washington Univ. School of Medicine
• 1986-92
  Anatomic Pathologist, Director of Cytopathology, Alta Bates Medical Ctr., Berkeley, CA
• 1989-93
  Associate Clinical Professor of Pathology, University of California San Francisco, CA
• 1993-present
  Professor of Clinical Pathology, University of California San Francisco, CA

---

Selected Publications

1. Rabban JT, Zaloudek CJ. A practical approach to immunohistochemical diagnosis of ovarian germ cell tumours and sex cord-stromal tumours. Histopathology. 2013 Jan; 62(1):71-88.
   View on PubMed
2. Karnezis AN, Aysal A, Zaloudek CJ, Rabban JT. Transitional Cell-like Morphology in Ovarian Endometrioid Carcinoma: Morphologic, Immunohistochemical, and Behavioral Features Distinguishing it From High-grade Serous Carcinoma. Am J Surg Pathol. 2013 Jan; 37(1):24-37.
   View on PubMed
3. Aysal A, Karnezis A, Medhi I, Grenert JP, Zaloudek CJ, Rabban JT. Ovarian endometrioid adenocarcinoma: incidence and clinical significance of the morphologic and immunohistochemical markers of mismatch repair protein defects and tumor microsatellite instability. Am J Surg Pathol. 2012 Feb; 36(2):163-72.
   View on PubMed
4. Powell CB, Chen LM, McLennan J, Crawford B, Zaloudek C, Rabban JT, Moore DH, Ziegler J. Risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol. Int J Gynecol Cancer. 2011 Jul; 21(5):846-51.
   View on PubMed
5. Rabban JT, Mackey A, Powell CB, Crawford B, Zaloudek CJ, Chen LM. Correlation of macroscopic and microscopic pathology in risk reducing salpingo-oophorectomy: implications for intraoperative specimen evaluation. Gynecol Oncol. 2011 Jun 1; 121(3):466-71.
   View on PubMed
6. Rabban JT, Karnezis AN, Zaloudek CJ. Junctional epithelial zones of the fallopian tube: cancer hotspots? Int J Gynecol Pathol. 2011 Jan; 30(1):1-3.
   View on PubMed
7. Rabban JT, McAlhany S, Lerwill MF, Grenert JP, Zaloudek CJ. PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma. Am J Surg Pathol. 2010 Feb; 34(2):137-46.
   View on PubMed
8. Rabban JT, Krasik E, Chen LM, Powell CB, Crawford B, Zaloudek CJ. Multistep level sections to detect occult fallopian tube carcinoma in risk-reducing salpingo-oophorectomies from women with BRCA mutations: implications for defining an optimal specimen dissection protocol. Am J Surg Pathol. 2009 Dec; 33(12):1878-85.
   View on PubMed
9. Rabban JT, Barnes M, Chen LM, Powell CB, Crawford B, Zaloudek CJ. Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma. Am J Surg Pathol. 2009 Aug; 33(8):1125-36.
   View on PubMed
10. Rabban JT, Lerwill MF, McCluggage WG, Grenert JP, Zaloudek CJ. Primary ovarian carcinoid tumors may express CDX-2: a potential pitfall in distinction from metastatic intestinal carcinoid tumors involving the ovary. Int J Gynecol Pathol. 2009 Jan; 28(1):41-8.
    View on PubMed
11. Rabban JT, Crawford B, Chen LM, Powell CB, Zaloudek CJ. Transitional cell metaplasia of fallopian tube fimbriae: a potential mimic of early tubal carcinoma in risk reduction salpingo-oophorectomies from women With BRCA mutations. Am J Surg Pathol. 2009 Jan; 33(1):111-9.
    View on PubMed
12. Hosfield EM, Rabban JT, Chen LM, Zaloudek CJ. Squamous metaplasia of the ovarian surface epithelium and subsurface fibrosis: distinctive pathologic findings in the ovaries and fallopian tubes of patients on peritoneal dialysis. Int J Gynecol Pathol. 2008 Oct; 27(4):465-74.
    View on PubMed
13. Rabban JT, Zaloudek CJ. Minimal uterine serous carcinoma: current concepts in diagnosis and prognosis. Pathology. 2007 Feb; 39(1):125-33.
    View on PubMed
14. Rabban JT, Gupta D, Zaloudek CJ, Chen LM. Synchronous ovarian granulosa cell tumor and uterine serous carcinoma: a rare association of a high-risk endometrial cancer with anestrogenic ovarian tumor. Gynecol Oncol. 2006 Dec; 103(3):1164-8.
    View on PubMed
15. Rabban JT, Swain RS, Zaloudek CJ, Chase DR, Chen YY. Immunophenotypic overlap between adenoid cystic carcinoma and collagenous spherulosis of the breast: potential diagnostic pitfalls using myoepithelial markers. Mod Pathol. 2006 Oct; 19(10):1351-7.
    View on PubMed
16. Cheng K, Pruitt L, Zaloudek C, Ries MD. Osteolysis caused by tibial component debonding in total knee arthroplasty. Clin Orthop Relat Res. 2006 Feb; 443:333-6.
    View on PubMed
17. Rabban JT, Zaloudek CJ, Shekitka KM, Tavassoli FA. Inflammatory myofibroblastic tumor of the uterus: a clinicopathologic study of 6 cases emphasizing distinction from aggressive mesenchymal tumors. Am J Surg Pathol. 2005 Oct; 29(10):1348-55.
    View on PubMed
18. Hansen EK, Krieg RM, Azar RJ, Jablons DM, Jahan TM, Zaloudek CJ. Unusual thoracic problems in patients with malignancies: case 3. Carcinoid tumor of the thymus. J Clin Oncol. 2005 Apr 20; 23(12):2859-61.
    View on PubMed
19. Powell CB, Kenley E, Chen LM, Crawford B, McLennan J, Zaloudek C, Komaromy M, Beattie M, Ziegler J. Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy. J Clin Oncol. 2005 Jan 1; 23(1):127-32.
    View on PubMed
20. Heerema-McKenney A, Harrison MR, Bratton B, Farrell J, Zaloudek C. Congenital teratoma: a clinicopathologic study of 22 fetal and neonatal tumors. Am J Surg Pathol. 2005 Jan; 29(1):29-38.
    View on PubMed

View on UCSF Profiles